34
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis

, , , , , , , , , , , , , , , & show all
Pages 323-329 | Received 31 Jan 2012, Accepted 20 Apr 2012, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jiu-Hua Zhao, Xiao-Lei Huang, Yu Duan, Yu-Jie Wang, Shan-Yu Chen & Jing Wang. (2017) Serum adipokines levels in patients with systemic sclerosis: A meta-analysis. Modern Rheumatology 27:2, pages 298-305.
Read now

Articles from other publishers (15)

João O. Pereira, Vânia Fernandes, Tiago M. Alfaro, Sara Freitas & Carlos Robalo Cordeiro. (2023) Diagnosis of Fibrotic Hypersensitivity Pneumonitis: Is There a Role for Biomarkers?. Life 13:2, pages 565.
Crossref
Giorgia Leodori, Chiara Pellicano, Valerio Basile, Amalia Colalillo, Luca Navarini, Antonietta Gigante, Francesca Gulli, Mariapaola Marino, Umberto Basile & Edoardo Rosato. (2022) Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis. Journal of Personalized Medicine 12:10, pages 1737.
Crossref
Neža Brezovec, Katja Perdan-Pirkmajer, Saša Čučnik, Snežna Sodin-Šemrl, John Varga & Katja Lakota. (2021) Adiponectin Deregulation in Systemic Autoimmune Rheumatic Diseases. International Journal of Molecular Sciences 22:8, pages 4095.
Crossref
Yoshihide Asano. (2020) The Pathogenesis of Systemic Sclerosis: An Understanding Based on a Common Pathologic Cascade across Multiple Organs and Additional Organ-Specific Pathologies. Journal of Clinical Medicine 9:9, pages 2687.
Crossref
Yoshihide Asano, Yuri Masui, Tetsuo Toyama & Shinichi Sato. (2019) Unique correlation profile of adiponectin and retinol‐binding protein 4 in patients with systemic sclerosis. The Journal of Dermatology 46:9, pages 819-820.
Crossref
Takashi Yamashita, Yoshihide Asano, Ryosuke Saigusa, Takashi Taniguchi, Megumi Hirabayashi, Takuya Miyagawa, Kouki Nakamura, Shunsuke Miura, Ayumi Yoshizaki, Maria Trojanowska & Shinichi Sato. (2019) Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis Vasculopathy. Journal of Investigative Dermatology 139:5, pages 1150-1160.
Crossref
Elena Neumann, Nina Lepper, Massimiliano Vasile, Valeria Riccieri, Marvin Peters, Florian Meier, Marie-Lisa Hülser, Oliver Distler, Steffen Gay, Poornima Mahavadi, Andreas Günther, Elke Roeb, Klaus W. Frommer, Magnus Diller & Ulf Müller-Ladner. (2019) Adipokine expression in systemic sclerosis lung and gastrointestinal organ involvement. Cytokine 117, pages 41-49.
Crossref
Hayakazu Sumida, Yoshihide Asano, Zenshiro Tamaki, Naohiko Aozasa, Takashi Taniguchi, Tetsuo Toyama, Takehiro Takahashi, Yohei Ichimura, Shinji Noda, Kaname Akamata, Ryosuke Saigusa, Miki Miyazaki, Yoshihiro Kuwano, Koichi Yanaba, Ayumi Yoshizaki & Shinichi Sato. (2018) Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study. The Journal of Dermatology 45:12, pages 1425-1433.
Crossref
Takashi Yamashita, Katja Lakota, Takashi Taniguchi, Ayumi Yoshizaki, Shinichi Sato, Wen Hong, Xingchun Zhou, Snezn Sodin-Semrl, Feng Fang, Yoshihide Asano & John Varga. (2018) An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis. Scientific Reports 8:1.
Crossref
Y. H. Lee & G. G. Song. (2016) Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosisMetaanalyse über die Plasmaspiegel von zirkulierendem Adiponectin, Leptin und Resistin bei systemischer Sklerose. Zeitschrift für Rheumatologie 76:9, pages 789-797.
Crossref
Katarzyna Winsz-Szczotka, Kornelia Kuźnik-Trocha, Katarzyna Komosińska-Vassev, Eugeniusz Kucharz, Anna Kotulska & Krystyna Olczyk. (2016) Relationship between adiponectin, leptin, IGF-1 and total lipid peroxides plasma concentrations in patients with systemic sclerosis: possible role in disease development. International Journal of Rheumatic Diseases 19:7, pages 706-714.
Crossref
Colin Ligon & Laura K. Hummers. (2016) Biomarkers in Scleroderma: Progressing from Association to Clinical Utility. Current Rheumatology Reports 18:3.
Crossref
T. Takahashi, Y. Asano, S. Noda, N. Aozasa, K. Akamata, T. Taniguchi, Y. Ichimura, T. Toyama, H. Sumida, Y. Kuwano, Y. Tada, M. Sugaya, T. Kadono & S. Sato. (2015) A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis. British Journal of Dermatology 173:3, pages 681-689.
Crossref
Kaname Akamata, Yoshihide Asano, Takashi Taniguchi, Takashi Yamashita, Ryosuke Saigusa, Kouki Nakamura, Shinji Noda, Naohiko Aozasa, Tetsuo Toyama, Takehiro Takahashi, Yohei Ichimura, Hayakazu Sumida, Yayoi Tada, Makoto Sugaya, Takafumi Kadono & Shinichi Sato. (2015) Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis. Rheumatology 54:7, pages 1308-1316.
Crossref
Shunsuke Miura, Yoshihide Asano, Ryosuke Saigusa, Takashi Yamashita, Takashi Taniguchi, Takehiro Takahashi, Yohei Ichimura, Tetsuo Toyama, Zenshiro Tamaki, Yayoi Tada, Makoto Sugaya, Shinichi Sato & Takafumi Kadono. (2015) Serum omentin levels: A possible contribution to vascular involvement in patients with systemic sclerosis. The Journal of Dermatology 42:5, pages 461-466.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.